retatrutide description Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam Demand for Unapproved Weight-Loss Drug

The more aggressive the weight loss becomes, the more important it is to focus on muscle preservation

Factors That Influence How Quickly Semaglutide Works Your starting weight affects response speedpeople with higher baseline weights often see faster initial loss because their caloric deficit is larger

Most DPP4i trials were of limited duration (2- to 4-year median follow up, except for CAROLINA) to detect renal or benefit for reductions in CVD from this therapeutic class (27)

The FDA has warned patients about using compounded semaglutide, as have a trio of obesity-medicine groups representing doctors and patients